Announcements Trials
Browse Landscape

Phase

Phase 2 104Phase 1 72Phase 1/2 39Phase NA 23Phase 3 12Phase 4 4Phase EARLY_PHASE1 2

Status

Completed 15Terminated 4Recruiting 4Unknown 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Sunitinib 1Sorafenib 1Single Person 1Interferons 1High-Energy Shock Waves 1Gemcitabine 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Carcinoma, Renal Cell × Clear all
NCT03821376 2024-10-10

Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

Indiana University

Phase 4 Terminated
12 enrolled 6 charts
Genitourinary

Carcinoma, Renal Cell

NCT02338570 2018-02-05

ORCHIDEE

Mario Negri Institute for Pharmacological Research

Phase 4 Terminated
31 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00930345 2015-04-01

PREINSUT

Assistance Publique - Hôpitaux de Paris

Phase 4 Terminated
33 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Bayer

Phase 4 Terminated
2 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡